numinus

Numinus’s Acquisition of Novamind May Signal More Consolidation to Come
An Investor Looks at Drug Development Strategies of Top Psychedelic Companies
How an Investor Evaluates Five Leading Psychedelic Therapy Companies
Psychedelics Reshape Questions About Bioethics and Religion
Numinus & Field Trip: A Tale of Two Strategies